Literature DB >> 19926673

Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus.

Chetan B Narshi, Seema Haider, Charlotte M Ford, David A Isenberg, Ian P Giles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19926673     DOI： 10.1093/rheumatology/kep356

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  17 in total

1.  Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus.

Authors:  Dongyan Shi; Dandan Wang; Xia Li; Huayong Zhang; Nan Che; Zhimin Lu; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2012-05       Impact factor: 2.980

2.  Plasmapheresis as rescue therapy for systemic lupus erthyematosus-associated diffuse alveolar haemorrhage.

Authors:  Simon Claridge; Partha Das; Anthony Dorling; Michael G Robson; Michael Robson
Journal:  BMJ Case Rep       Date:  2011-03-15

Review 3.  B-cell-targeted therapies in systemic lupus erythematosus.

Authors:  Vera Sau-Fong Chan; Helen Hoi-Lun Tsang; Rachel Chun-Yee Tam; Liwei Lu; Chak-Sing Lau
Journal:  Cell Mol Immunol       Date:  2013-01-28       Impact factor: 11.530

Review 4.  Rituximab and lupus--a promising pair?

Authors:  Sara Linder Ekö; Ronald F van Vollenhoven
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

5.  Diffuse alveolar hemorrhage: a rare life-threatening condition in systemic lupus erythematosus.

Authors:  Ravi Paul Singh Virdi; Adeel Bashir; Ghulamullah Shahzad; Javed Iqbal; Jose O Mejia
Journal:  Case Rep Pulmonol       Date:  2012-05-27

6.  Pathogenic role of B cells in the development of diffuse alveolar hemorrhage induced by pristane.

Authors:  Tolga T Barker; Pui Y Lee; Kindra M Kelly-Scumpia; Jason S Weinstein; Dina C Nacionales; Yutaro Kumagai; Shizuo Akira; Byron P Croker; Eric S Sobel; Westley H Reeves; Minoru Satoh
Journal:  Lab Invest       Date:  2011-08-01       Impact factor: 5.662

7.  Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report.

Authors:  Emily M Baird; Thomas Ja Lehman; Stefan Worgall
Journal:  Pediatr Rheumatol Online J       Date:  2011-10-27       Impact factor: 3.054

8.  Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience.

Authors:  Yolanda Braun-Moscovici; Yonatan Butbul-Aviel; Ludmila Guralnik; Kochava Toledano; Doron Markovits; Alexander Rozin; Menahem A Nahir; Alexandra Balbir-Gurman
Journal:  Rheumatol Int       Date:  2012-12-14       Impact factor: 3.580

9.  Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival.

Authors:  Nayef M Kazzaz; Patrick Coit; Emily E Lewis; W Joseph McCune; Amr H Sawalha; Jason S Knight
Journal:  Lupus Sci Med       Date:  2015-09-23

10.  Systemic lupus erythematosus-associated diffuse alveolar hemorrhage: A case report and review of the literature.

Authors:  Luisa Morales-Nebreda; Omolola Alakija; Keith T Ferguson; Benjamin D Singer
Journal:  Clin Pulm Med       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.